These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24747632)

  • 1. Effects of enoxaparin and rivaroxaban on tissue survival in skin degloving injury: an experimental study.
    Azboy I; Demirtaş A; Bulut M; Alabalik U; Uçar Y; Alemdar C
    Acta Orthop Traumatol Turc; 2014; 48(2):212-6. PubMed ID: 24747632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model of degloving injury in rats: effect of allopurinol and pentoxifylline in improving viability of avulsed flaps.
    Milcheski DA; Nakamoto HA; Tuma P; Nóbrega L; Ferreira MC
    Ann Plast Surg; 2013 Mar; 70(3):366-9. PubMed ID: 21921788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pentoxifylline in treatment of skin degloving injuries: an experimental study.
    Oztuna V; Eskandari MM; Unal S; Colak M; Karabacak T
    Injury; 2006 Jul; 37(7):638-41. PubMed ID: 16769312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of rivaroxaban and enoxaparin on blood loss after total knee arthroplasty].
    Li J; Jing J; Zhou Y; Yao Y; Zhan J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jan; 28(1):26-9. PubMed ID: 24693773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the effects of Enoxaparin, Fondaparinux, and Rivaroxaban used in thromboembolism prophylaxis on fracture healing in rats.
    Demirtas A; Azboy I; Bulut M; Ucar BY; Alabalik U; Necmioglu NS
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1850-6. PubMed ID: 23877846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the effects of heparin and enoxaparin on degloving injuries.
    Cebesoy O; Isik M; Erzincan T; Pamukcu U; Bilgin F; Subasi M
    Bratisl Lek Listy; 2014; 115(9):550-3. PubMed ID: 25318913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis.
    Parry TJ; Huang Z; Chen C; Connelly MA; Perzborn E; Andrade-Gordon P; Damiano BP
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):720-6. PubMed ID: 21986468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of effects of two anticoagulants on hidden blood loss after total hip arthroplasty].
    Li J; Zhou Y; Jing J; Zhan J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Apr; 27(4):432-5. PubMed ID: 23757870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for coagulation factor Xa in experimental pulmonary arterial hypertension.
    Delbeck M; Nickel KF; Perzborn E; Ellinghaus P; Strassburger J; Kast R; Laux V; Schäfer S; Schermuly RT; von Degenfeld G
    Cardiovasc Res; 2011 Oct; 92(1):159-68. PubMed ID: 21676958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
    Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
    Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dabigatran and fondaparinux on degloving injuries: An experimental study.
    Ural A; Bilgen F; Altıntaş Aykan D; Bahar AY; Bekerecioğlu M; Altıntaş Ural D
    Ulus Travma Acil Cerrahi Derg; 2020 May; 26(3):343-350. PubMed ID: 32436968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of vasonatrin peptide on random pattern skin flap survival.
    Wang SP; Lan ZY; Xia W; Zhao X; Ma GJ; Liu B; Pan BH; Guo SZ
    Ann Plast Surg; 2014 Jan; 72(1):94-9. PubMed ID: 23403542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hyperbaric oxygen therapy on healing in an experimental model of degloving injury in tails of nicotine-treated rats.
    Demirtas A; Azboy I; Bulut M; Ucar BY; Alabalik U; Ilgezdi S
    J Hand Surg Eur Vol; 2013 May; 38(4):405-11. PubMed ID: 23221280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos AC; Tapson V;
    N Engl J Med; 2013 Feb; 368(6):513-23. PubMed ID: 23388003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiment study on ultrashort wave for treating vascular crisis after rat tail replantation].
    Tan L; Gao W; Xi A; Wang C; Chen S; Zhao Y; Di K; Yang X; Weng S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Oct; 26(10):1227-31. PubMed ID: 23167109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the factor Xa inhibitor rivaroxaban on arterial thrombosis in wild-type and apolipoprotein E-deficient mice.
    Wagner NM; Dressel T; Schäfer K; Konstantinides S
    Thromb Res; 2012 Nov; 130(5):793-8. PubMed ID: 22281071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
    Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
    N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
    Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
    J Med Econ; 2011; 14(6):824-34. PubMed ID: 22023098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
    Turpie AG; Lassen MR; Eriksson BI; Gent M; Berkowitz SD; Misselwitz F; Bandel TJ; Homering M; Westermeier T; Kakkar AK
    Thromb Haemost; 2011 Mar; 105(3):444-53. PubMed ID: 21136019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
    Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
    N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.